Florence van Hunsel, PharmD, PhD

Lead Safety Innovation
Netherlands Pharmacovigilance Centre Lareb, Netherlands

Florence van Hunsel, PharmD, PhD, is Lead Safety Innovation of the Netherlands Pharmacovigilance Centre Lareb. She has been working at Lareb since 2005. She is a Pharmacist and Epidemiologist with expertise in (statistical) signal detection, causality assessment and patient involvement in pharmacovigilance. She is a member of the ISPE Vaccine SIG.

Poster(s):

• (046) Differences in Time to Onset Between Spontaneous Reports and Cohort Studies: The Case of the COVID-19 Vaccines
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (049) The role of comorbidities in the development of AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (128) Clinical Quality of Information of Primary Pregnancy Pharmacovigilance Data Sources – A ConcePTION Project
  Sunday, August 27, 2023

  8:00 AM – 1:30 PM ADT

• (A53) Safety monitoring of COVID-19 vaccines in multiple European countries: initial results from the COVID-19 Vaccine Monitor (CVM)
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT

• (A54) The effect of sex on the incidence, latency, duration and burden of adverse events following influenza vaccination
  Friday, August 25, 2023

  8:00 AM – 6:00 PM ADT